Healthcare -
Biotechnology - NASDAQ - US
$ 8.71
-2.21 %
$ 327 M
Market Cap
4.73
P/E
TRDA - CASH FROM OPERATIONS
Cash from Operations TRDA - Entrada Therapeutics, Inc.
-41.6 M
LAST VALUE
33.43%
2 YEAR CAGR
-30.93%
5 YEAR CAGR
0.00%
10 YEAR CAGR